Here we show distinct candidate drugs having a variable effect depending on the multiplicity of infection (MOI) of virus infection in A549-ACE2 expressing cells in low (MOI 0.2; Fig. 4A) and high MOI (2.0; Fig. 4B). This evidence concerns the gene ACE2 and viral infectious disease.